BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright ©The Author(s) 2026.
World J Gastrointest Endosc. Jan 16, 2026; 18(1): 111395
Published online Jan 16, 2026. doi: 10.4253/wjge.v18.i1.111395
Table 1 Comparison of pH impedance parameters between different patient categories, mean ± SD, 95% confidence interval
Metrics per 24 hours
ERD (n = 13)
NERD (n = 8)
RH (n = 8)
FH (n = 6)
ERD with AET > 4% (n = 5)
AET > 4% (n = 13)
P value (ERD vs NERD)1
P value (ERD with high AET vs NERD)1
P value (high AET vs RH)1
P value (high AET vs FH)1
P value (FH vs RH)1
Acid exposure time (%)4.0 ± 4.3, 1.4-6.59.2 ± 5.1, 4.9-13.41.3 ± 1.1, 0.4-2.21.3 ± 0.9, 0.33-2.28.4 ± 3.6, 3.9-12.88.9 ± 4.4, 6.1-11.50.0150.826< 0.0010.0010.948
Total reflux events52.6 ± 50.9, 21.8-83.355.7 ± 33.1, 28-8340.2 ± 32.5, 13-67.323.6 ± 28.0, -5.8 to 52.998.1 ± 55.9, 28.7-167.572.0 ± 46.3, 44-1000.4690.1430.1480.0160.121
SI for impedance refluxes (%)24.6 ± 35.1, 3.4-45.814.7 ± 21.9, -3.6 to 3329.7 ± 23.2, 10.2-490.2 ± 0.4, 0.2-0.556.5 ± 39.5, 7.5-105.530.8 ± 35.3, 9.4-52.10.4810.0380.5100.0790.002
SSI for impedance refluxes (%)13.1 ± 21.3, 0.2-25.92.8 ± 5.0, -1.3 to 6.925.7 ± 21.8, 7.5-43.94.2 ± 10.2, -6.5 to 14.815.3 ± 13.3, -1.2 to 31.97.6 ± 10.7, 1.1-14.00.2730.0770.0100.2040.012
SAP for impedance refluxes (%)45.1 ± 50.3, 14.6-75.436.3 ± 50.2, -5.6 to 7896.4 ± 9.0, 88.8-103.96.5 ± 15.9, -10.1 to 2379.8 ± 44.6, 24.4-135.253.1 ± 51.2, 22.1-83.90.4330.0360.1110.0780.001
Distal MNBI (3, 5, 7, 9)2452.3 ± 1042.9, 1822-30821158.3 ± 350.5, 865-14512526.0 ± 727.5, 1917-31342561.1 ± 651.7, 1877-32451751.8 ± 769.1, 796.8-2706.61386.6 ± 599.3, 1024.4-1748.60.0010.0790.0040.0070.699
PSPW index (%)86.6 ± 57.7, 51.7-121.561.4 ± 18.5, 45.9-76.883.3 ± 18.1, 68.2-98.468.9 ± 30.9, 36.4-101.361.3 ± 23.8, 31.8-90.761.4 ± 19.7, 49.4-73.20.1471.0000.0110.5980.604
Table 2 Patient characteristics of erosive reflux disease, non-erosive reflux disease, reflux hypersensitivity, and functional heartburn, n (%)/mean ± SD, 95% confidence interval
Metrics per 24 hours
NERD (n = 8)
ERD with AET > 4% (n = 5)
AET > 4% (n = 13)
RH (n = 8)
FH (n = 6)
P value (ERD with high AET vs NERD)
P value (high AET vs RH)
P value (high AET vs FH)
P value (FH vs RH)
Symptom characteristics
Satisfactory response to anti-reflux treatment5 (62.5)4 (80)9 (69.2)5 (62.5)3 (50)1.00011.010.61711.0001
GERD screening tool score56.75 ± 20.6, 39.5-7445.4 ± 14.1, 27.8-62.952.4 ± 18.6, 41.1-63.666.3 ± 39.3, 33.4-9952.3 ± 23.0, 28.1-76.50.37710.88511.00010.7461
Heartburn score13.9 ± 7.6, 7.5-20.29.4 ± 5.6, 0.7-18.012.2 ± 7.4, 7.7-16.612.6 ± 3.5, 9.6-15.511.2 ± 7.5, 3.3-19.00.36410.82510.78610.3581
Regurgitation score9.8 ± 6.9, 4-15.414.8 ± 5.6, 7.8-21.711.7 ± 6.7, 7.7-15.713.0 ± 8.6, 5.8-20.113.3 ± 7.0, 5.9-20.70.15610.76510.50310.7871
Chest pain score10.3 ± 5.6, 5.5-14.99.4 ± 5.6, 2.5-16.29.9 ± 5.4, 6.7-13.110.0 ± 8.6, 2.8-17.15.0 ± 4.8, 0.1-10.01.00010.74110.09110.3191
Bloating score10.1 ± 6.8, 4.4-15.81.0 ± 06.6 ± 7, 2.4-10.89.4 ± 8.2, 2.4-16.25.7 ± 7.9, 2.6-13.90.00710.36910.63410.2801
Dysphagia score2.8 ± 3.2, 0.4-5.43.8 ± 6.3, -3.9 to 11.53.2 ± 4.4, 0.48-5.86.4 ± 7.6, 0.006-12.74.3 ± 7.7, -3.7 to 12.41.00010.18110.65110.5661
Cough score4.8 ± 7.3, -1.3 to 10.83.2 ± 4.9, -2.9 to 9.34.2 ± 6.3, 0.36-7.95.8 ± 6.8, 0.08-11.48.0 ± 8.3, -0.7 to 16.70.76610.52510.26410.6161
Burping score7.0 ± 5.0, 2.8-11.15.4 ± 1.5, 3.5-7.26.4 ± 4.0, 3.9-8.77.8 ± 5.3, 3.3-12.14.8 ± 4.0, 0.6-9.00.70910.60610.47010.2881
Factors associated with GERD symptoms
Age (years)38.8 ± 9.9, 39-4332.8 ± 6.6, 25-4136.5 ± 8.9, 31-4134.8 ± 9.9, 26.5-4335.8 ± 9.7, 25.6-460.16310.69010.86010.7471
Sex (male)3 (37.5)3 (60)6 (46.2)4 (50)5 (83.3)0.59221.020.17720.3012
Married5 (62.5)2 (40)7 (53.8)5 (62.5)4 (66.7)0.59221.021.00021.02
PSS score17.0 ± 6.3, 11.7-22.212.2 ± 1.9, 9.8-14.615.1 ± 5.5, 11.8-18.513.9 ± 5.3, 9.4-18.315.0 ± 3.6, 11.2-18.70.05510.42110.82410.3931
Abdominal obesity (Asian cutoffs)2 ± 253 ± 605 ± 38.53 ± 37.51 ± 16.70.29321.020.60520.5802
BMI (kg/m2)25.8 ± 4.2, 22.2-29.326.0 ± 4.7, 29.3-31.925.9 ± 4.2, 23.3-28.423.0 ± 3.8, 19.8-26.222.7 ± 2.5, 20-25.30.77010.11110.11410.9481
Physical activity level (MET minute/week)211.1 ± 433.3, -151 to 5731076.4 ± 1439.1, 710-2863543.9 ± 995.9, -57.8 to 1145.7914.1 ± 890.1, 169.3-16583409.0 ± 4040.1, -830 to 76480.08010.10910.01310.2451
History of abdominal surgery2 (25)1 (20)3 (23.1)2 (25)1 (16.7)1.00021.00021.00021.0002
Those with asthma0 (0)0 (0)0 (0)2 (25)2 (33.3)-0.13320.08821.0002
Those with diabetes mellitus2 (25)0 (0)2 (15.4)0 (0)0 (0)0.48720.50521.0002-
Caloric intake (kcal)2235.0 ± 732.7, 1622-28471944.4 ± 684.1, 1094.9-2793.82123.3 ± 700.6, 1699-25461861.7 ± 539.9, 1410-23132083.9 ± 219.6, 1853-23140.38010.34610.79210.5191
Carbohydrate intake (g)420.3 ± 141.2, 302-538348.2 ± 132.4, 183.7-512.6392.6 ± 137.1, 309.6-475.4323.4 ± 91.3, 247-399.6349.0 ± 54.0, 292.3-405.70.38010.31110.59910.6991
Fat intake (g)34.9 ± 13.1, 23.9-45.735.5 ± 18.3, 12.7-58.235.1 ± 14.5, 26.3-43.940.9 ± 21.6, 22.8-58.936.0 ± 8.3, 27.2-44.61.00010.77210.48310.8971
Protein intake (g)55.6 ± 18.5, 40-7161.1 ± 12.9, 45.1-77.157.7 ± 16.2, 47.8-67.551.3 ± 19.2, 35.2-67.351.0 ± 7.8, 42.8-59.20.66110.19210.18810.5191
Fiber intake (g)22.7 ± 11.8, 12.7-32.520.8 ± 10.1, 8.2-33.321.9 ± 10.8, 15.4-28.418.3 ± 10.0, 9.9-26.622.8 ± 9.5, 12.7-32.80.66110.34610.93010.3661
Symptoms for spicy food6 (75)3 (60)9 (69.2)7 (87.5)4 (66.7)1.00020.60621.00020.5382
Symptoms for oily food5 (62.5)3 (60)8 (61.5)7 (87.5)4 (66.7)1.00020.33621.00020.5382
Symptoms for wheat-based food2 (25)2 (40)4 (30.8)6 (75)4 (66.7)1.00020.08020.31921.0002
Symptoms for bread5 (62.5)3 (60)8 (61.5)6 (75)5 (83.3)1.00020.65620.60521.0002
Table 3 Summary of key findings from the present study and compared with selected international studies
Ref.
Sample size
Esophagitis (%)
Barrett’s esophagus (%)
Abnormal AET (%)
Present study, 202520933% (n = 199)3% (n = 199)28% (n = 46)
Ye et al[141], 201711031%NR31%
Ford et al[142], 2010> 500013.4%NRNR
Dent et al[23], 201020357%NR64.9%
Xiao et al[143], 20096431.3%NR34.4%